Celcuity, Inc. (CELC)
65.68
-5.57
(-7.82%)
USD |
NASDAQ |
Oct 07, 16:00
66.73
+1.05
(+1.60%)
After-Hours: 19:41
Celcuity Enterprise Value : 3.486B for Oct. 6, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 06, 2026 | 3.486B |
| October 05, 2026 | 3.602B |
| October 02, 2026 | 3.528B |
| October 01, 2026 | 3.676B |
| September 30, 2026 | 3.891B |
| September 29, 2026 | 3.786B |
| September 28, 2026 | 3.897B |
| September 25, 2026 | 3.891B |
| September 24, 2026 | 3.883B |
| September 23, 2026 | 3.914B |
| September 22, 2026 | 4.115B |
| September 21, 2026 | 4.110B |
| September 18, 2026 | 3.944B |
| September 17, 2026 | 4.154B |
| September 16, 2026 | 4.040B |
| September 15, 2026 | 4.046B |
| September 14, 2026 | 4.087B |
| September 11, 2026 | 4.083B |
| September 10, 2026 | 4.183B |
| September 09, 2026 | 4.407B |
| September 08, 2026 | 4.551B |
| September 04, 2026 | 4.682B |
| September 03, 2026 | 4.718B |
| September 02, 2026 | 4.707B |
| September 01, 2026 | 4.500B |
| Date | Value |
|---|---|
| August 31, 2026 | 4.357B |
| August 28, 2026 | 4.327B |
| August 27, 2026 | 4.562B |
| August 26, 2026 | 4.652B |
| August 25, 2026 | 4.514B |
| August 24, 2026 | 4.442B |
| August 21, 2026 | 4.576B |
| August 20, 2026 | 4.431B |
| August 19, 2026 | 4.582B |
| August 18, 2026 | 4.562B |
| August 17, 2026 | 4.523B |
| August 14, 2026 | 4.501B |
| August 13, 2026 | 4.237B |
| August 12, 2026 | 4.505B |
| August 11, 2026 | 4.311B |
| August 10, 2026 | 4.442B |
| August 07, 2026 | 4.539B |
| August 06, 2026 | 4.562B |
| August 05, 2026 | 4.546B |
| August 04, 2026 | 4.525B |
| August 03, 2026 | 4.292B |
| July 31, 2026 | 4.226B |
| July 30, 2026 | 4.288B |
| July 29, 2026 | 4.074B |
| July 28, 2026 | 4.034B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Sarepta Therapeutics, Inc. | 2.086B |
| Twist Bioscience Corp. | 10.39B |
| Beam Therapeutics, Inc. | 1.700B |
| Vera Therapeutics, Inc. | 1.693B |
| Tango Therapeutics, Inc. | 2.706B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -78.86M |
| Total Expenses (Quarterly) | 78.86M |
| EPS Diluted (Quarterly) | -1.439 |
| Earnings Yield | -6.55% |
| Normalized Earnings Yield | -6.323 |